Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00512551 · ClinicalTrials.gov registry record
DNA Array Analysis of Patients With Cervical Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 18
- Enrollment target
NCT00512551: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00512551 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00512551 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to find out if the expression of certain genes is linked with the response of cervical cancer to radiation. Researchers will study a large number of genes located in tumor material to learn this information.
Interventions
- PROCEDURE Tumor Biopsies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2000-06-20 |
| Est. Completion | 2017-11-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00512551
The ClinicalTrials.gov registry entry for NCT00512551 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tumor Biopsies is the first listed.
NCT00512551 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00512551 about?
NCT00512551 is a clinical study titled "DNA Array Analysis of Patients With Cervical Cancer". The goal of this clinical research study is to find out if the expression of certain genes is linked with the response of cervical cancer to radiation. Researchers will study a large number of genes located in tumor material to learn this information.
What is the current status of trial NCT00512551?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2000-06-20. Estimated completion is 2017-11-20.
What interventions are being tested in trial NCT00512551?
The interventions under investigation include: Tumor Biopsies (PROCEDURE).
Who is sponsoring clinical trial NCT00512551?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.